Peter Connelly

2.2k total citations
33 papers, 439 citations indexed

About

Peter Connelly is a scholar working on Psychiatry and Mental health, General Health Professions and Physiology. According to data from OpenAlex, Peter Connelly has authored 33 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 9 papers in General Health Professions and 6 papers in Physiology. Recurrent topics in Peter Connelly's work include Dementia and Cognitive Impairment Research (13 papers), Alzheimer's disease research and treatments (3 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Peter Connelly is often cited by papers focused on Dementia and Cognitive Impairment Research (13 papers), Alzheimer's disease research and treatments (3 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Peter Connelly collaborates with scholars based in United Kingdom, United States and Australia. Peter Connelly's co-authors include Emma Law, Neil Prentice, G. J. Naylor, Kieran C. Breen, Jim Bonham, Rachel Sayer, John M. Starr, Mario A. Parra, Tom C. Russ and Roberta James and has published in prestigious journals such as Diabetes Care, Biological Psychiatry and The British Journal of Psychiatry.

In The Last Decade

Peter Connelly

30 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Connelly United Kingdom 11 156 130 73 64 50 33 439
Martin Burkart Germany 18 302 1.9× 138 1.1× 59 0.8× 67 1.0× 133 2.7× 48 860
Sophie Gillette‐Guyonnet France 9 234 1.5× 278 2.1× 35 0.5× 58 0.9× 34 0.7× 13 558
Chay‐Hoon Tan Singapore 14 270 1.7× 83 0.6× 55 0.8× 22 0.3× 45 0.9× 24 592
F. Latour France 12 318 2.0× 159 1.2× 84 1.2× 61 1.0× 14 0.3× 28 577
Bryan Shapiro United States 12 106 0.7× 139 1.1× 51 0.7× 40 0.6× 13 0.3× 25 733
Mary Ganguli United States 11 386 2.5× 280 2.2× 54 0.7× 99 1.5× 30 0.6× 17 787
A. Pfeffer Poland 8 232 1.5× 146 1.1× 36 0.5× 15 0.2× 91 1.8× 14 443
Peak‐Chiang Chiam Singapore 7 132 0.8× 226 1.7× 53 0.7× 71 1.1× 11 0.2× 7 616
Hyun Jeong Han South Korea 16 243 1.6× 211 1.6× 119 1.6× 26 0.4× 28 0.6× 51 595
Elena Mariani Italy 12 206 1.3× 199 1.5× 23 0.3× 71 1.1× 28 0.6× 13 682

Countries citing papers authored by Peter Connelly

Since Specialization
Citations

This map shows the geographic impact of Peter Connelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Connelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Connelly more than expected).

Fields of papers citing papers by Peter Connelly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Connelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Connelly. The network helps show where Peter Connelly may publish in the future.

Co-authorship network of co-authors of Peter Connelly

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Connelly. A scholar is included among the top collaborators of Peter Connelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Connelly. Peter Connelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pennington, Catherine, Harriet A. Ball, Peter Connelly, et al.. (2025). Development of the Clinical Insight Questionnaire: A Novel Clinical Tool for the Assessment of Insight Into Cognitive Symptoms and Everyday Functioning in People With Neurodegeneration. International Journal of Geriatric Psychiatry. 40(11). e70165–e70165.
2.
Doney, Alex S. F., Yu Huang, Emanuele Trucco, et al.. (2022). Retinal vascular measures from diabetes retinal screening photographs and risk of incident dementia in type 2 diabetes: A GoDARTS study. Frontiers in Digital Health. 4. 945276–945276. 2 indexed citations
3.
Doney, Alex S. F., Emily Jefferson, Katherine E. Walesby, et al.. (2019). Investigating the Relationship Between Type 2 Diabetes and Dementia Using Electronic Medical Records in the GoDARTS Bioresource. Diabetes Care. 42(10). 1973–1980. 9 indexed citations
4.
5.
Connelly, Peter, et al.. (2018). The Effect of Understanding Issues of Personal Finance on the Well-being of Physicians in Training.. PubMed. 117(4). 164–166. 12 indexed citations
6.
Parra, Mario A., Alison E. Lim, Peter Connelly, & John M. Starr. (2016). Prediction of general hospital admission in people with dementia. 1 indexed citations
7.
Russ, Tom C., et al.. (2014). Prediction of general hospital admission in people with dementia: Cohort study. The British Journal of Psychiatry. 206(2). 153–159. 31 indexed citations
8.
Law, Emma, Tom C. Russ, & Peter Connelly. (2013). What motivates patients and carers to participate in dementia studies?. Nursing Older People. 25(9). 31–36. 9 indexed citations
9.
Ritchie, Karen, David Ames, James R. Burke, et al.. (2011). An international perspective on advanced neuroimaging: cometh the hour or ivory tower?. International Psychogeriatrics. 23. S58–S64. 1 indexed citations
10.
Connelly, Peter, et al.. (2009). Fifteen year comparison of antipsychotic use in people with dementia within hospital and nursing home settings: sequential cross‐sectional study. International Journal of Geriatric Psychiatry. 25(2). 160–165. 6 indexed citations
11.
Connelly, Peter, et al.. (2007). A randomised double‐blind placebo‐controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease. International Journal of Geriatric Psychiatry. 23(2). 155–160. 70 indexed citations
12.
Connelly, Peter. (2005). Predicting the outcome of cholinesterase inhibitor treatment in Alzheimer's disease. Journal of Neurology Neurosurgery & Psychiatry. 76(3). 320–324. 41 indexed citations
13.
Connelly, Peter & Roberta James. (2005). SIGN guideline for the management of patients with dementia. International Journal of Geriatric Psychiatry. 21(1). 14–16. 7 indexed citations
14.
Connelly, Peter, et al.. (2005). Hypertension, white matter change and response to cholinesterase inhibitors in Alzheimer's disease. International Journal of Geriatric Psychiatry. 20(7). 623–628. 14 indexed citations
15.
Connelly, Peter & Neil Prentice. (2004). Current Smoking and Response to Cholinesterase Inhibitor Therapy in Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders. 19(1). 11–14. 6 indexed citations
16.
Findlay, D.J.S. & Peter Connelly. (2003). Memantine (Ebixa®) in the later stages of dementia. Hospital Medicine. 64(11). 654–657. 3 indexed citations
17.
Sayer, Rachel, Emma Law, Peter Connelly, & Kieran C. Breen. (2003). Association of a salivary acetylcholinesterase with Alzheimer's disease and response to cholinesterase inhibitors. Clinical Biochemistry. 37(2). 98–104. 70 indexed citations
18.
Connelly, Peter. (1993). Antipsychotic drugs in continuing care: A 2‐year follow‐up audit. International Journal of Geriatric Psychiatry. 8(3). 261–264. 3 indexed citations
19.
Connelly, Peter. (1988). The Ideology of Pope's Iliad. Comparative Literature. 40(4). 358–358. 2 indexed citations
20.
Naylor, G. J., F. M. Corrigan, Anne H. W. Smith, Peter Connelly, & Neil Ward. (1987). Further Studies of Vanadium in Depressive Psychosis. The British Journal of Psychiatry. 150(5). 656–661. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin Burkart Breakdown of academic impact, for papers by Sophie Gillette‐Guyonnet Breakdown of academic impact, for papers by Chay‐Hoon Tan Breakdown of academic impact, for papers by F. Latour Breakdown of academic impact, for papers by Bryan Shapiro Breakdown of academic impact, for papers by Mary Ganguli Breakdown of academic impact, for papers by A. Pfeffer Breakdown of academic impact, for papers by Peak‐Chiang Chiam Breakdown of academic impact, for papers by Hyun Jeong Han Breakdown of academic impact, for papers by Elena Mariani
Rankless by CCL
2026